SIRT4 regulates cancer cell survival and growth after stress

Seung Min Jeong1, Sunsook Hwang2, Rho Hyun Seong2

  • 1Department of Biochemistry, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea; Institute for Aging and Metabolic Diseases, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea.

Insights

Mitochondrial SIRT4 protein is crucial for cancer cell survival and resistance to cellular stress. Its absence sensitizes cancer cells to DNA damage and ER stress, highlighting its potential as a therapeutic target.

Area of Science:

  • Cellular biology
  • Cancer research
  • Mitochondrial function

Background:

  • Cellular stress response pathways are vital for homeostasis.
  • Defects in stress response lead to cell death.
  • Mitochondrial SIRT4's role in cancer cell survival and drug resistance is unclear.

Purpose of the Study:

  • To investigate the role of SIRT4 in cancer cell stress resistance.
  • To determine if SIRT4 is essential for cancer cell survival and tumorigenesis.

Main Methods:

  • Induction of SIRT4 under various cellular stresses.
  • Assessment of cell survival and growth after stress in wild-type and SIRT4-deficient cells.
  • Evaluation of cancer cell vulnerability to oncogene activation in SIRT4 null cells.

Main Results:

  • SIRT4 is highly induced by cellular stresses.
  • SIRT4 promotes cancer cell survival and growth post-stress.
  • SIRT4 deficiency increases sensitivity to DNA damage and ER stress.
  • SIRT4 is required for tumorigenic transformation and protects against oncogene-induced stress.

Conclusions:

  • SIRT4 is a critical regulator of cancer cell stress resistance.
  • SIRT4 plays essential roles in cell survival, growth, and tumorigenesis.
  • SIRT4 represents a potential therapeutic target for cancer treatment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

4.2K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K